GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
SFTA2 |
Q6UW10
|
surfactant associated 2
|
|
3.6E-02 |
0.695 |
0.577 |
CCHCR1 |
Q8TD31
|
coiled-coil alpha-helical rod protein 1
|
|
1.0E-16 |
0.505 |
0.808 |
TCF19 |
Q9Y242
|
transcription factor 19
|
|
9.4E-04 |
0.674 |
0.692 |
GPSM3 |
Q9Y4H4
|
G protein signaling modulator 3
|
|
0.29 |
0.751 |
0.423 |
GGNBP1 |
Q5YKI7
|
gametogenetin binding protein 1 (pseudogene)
|
|
0.69 |
0.769 |
0.462 |
BRAP |
Q7Z569
|
BRCA1 associated protein
|
|
3.8E-06 |
0.612 |
0.769 |
EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
COL11A2P1 |
|
collagen type XI alpha 2 pseudogene 1
|
|
|
0.805 |
0.462 |
HLA-DPA2 |
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene)
|
|
|
0.780 |
0.538 |
YDJC |
A8MPS7
|
YdjC chitooligosaccharide deacetylase homolog
|
|
6.2E-02 |
0.805 |
0.231 |
HLA-DPB2 |
|
major histocompatibility complex, class II, DP beta 2 (pseudogene)
|
|
|
0.743 |
0.500 |
HLA-DPA3 |
|
major histocompatibility complex, class II, DP alpha 3 (pseudogene)
|
|
|
0.805 |
0.308 |
THPO |
P40225
|
thrombopoietin
|
|
0.20 |
0.513 |
0.692 |
HLA-DQB3 |
|
major histocompatibility complex, class II, DQ beta 3
|
|
|
0.931 |
0.192 |
ZNF285B |
|
zinc finger protein 285B (pseudogene)
|
|
|
1.000 |
0.077 |
RING1 |
Q06587
|
ring finger protein 1
|
|
0.65 |
0.653 |
0.423 |
RPL32P1 |
|
ribosomal protein L32 pseudogene 1
|
|
|
1.000 |
0.077 |
KIF1B |
O60333
|
kinesin family member 1B
|
Cellular structure
|
1.00 |
0.516 |
0.808 |
HBS1L |
Q9Y450
|
HBS1 like translational GTPase
|
Enzyme
|
1.9E-07 |
0.705 |
0.462 |